Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
38,743
datasets available to search
ShareScore release 0.9.0
Dataset results
38,743 results for “efficacy”
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequ
ClinicalTrials.gov study NCT01500278. IPD Sharing: Not stated. Countries: 20. Publications: 3.
The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery
ClinicalTrials.gov study NCT02188576. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
ClinicalTrials.gov study NCT02128490. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease
ClinicalTrials.gov study NCT01133860. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia
ClinicalTrials.gov study NCT02969382. IPD Sharing: YES. Countries: 5. Publications: 2.
Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients
ClinicalTrials.gov study NCT00257686. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
ClinicalTrials.gov study NCT01072929. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT02850965. IPD Sharing: Not stated. Countries: 8. Publications: 3.
A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.
ClinicalTrials.gov study NCT00282464. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
ClinicalTrials.gov study NCT02105987. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01807221. IPD Sharing: Not stated. Countries: 25. Publications: 4.
A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety
ClinicalTrials.gov study NCT04644484. IPD Sharing: NO. Countries: 1. Publications: 4.
Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy
ClinicalTrials.gov study NCT02607735. IPD Sharing: YES. Countries: 8. Publications: 3.
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01885208. IPD Sharing: Not stated. Countries: 13. Publications: 18.
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease
ClinicalTrials.gov study NCT01584440. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device
ClinicalTrials.gov study NCT03637374. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
ClinicalTrials.gov study NCT02281318. IPD Sharing: YES. Countries: 19. Publications: 7.
Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
ClinicalTrials.gov study NCT02943460. IPD Sharing: NO. Countries: 4. Publications: 1.
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alp
ClinicalTrials.gov study NCT00468546. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.
ClinicalTrials.gov study NCT00328627. IPD Sharing: Not stated. Countries: 19. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.